Recombinant CD248 (Ontuxizumab Biosimilar) antibody

Catalog No. ABIN7597879

The Humanized Chimeric anti-CD248 (Ontuxizumab Biosimilar) antibody is suitable to detect CD248 (Ontuxizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD248 (Ontuxizumab Biosimilar) antibody (ABIN7597879)

Target: CD248 (Ontuxizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: Un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Research Grade Ontuxizumab Biosimilar Antibody

Specificity: Endosialin, TEM1, CD164L1, Tumor endothelial marker 1, CD248

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details

Target: CD248 (Ontuxizumab Biosimilar)

Alternative Name: Ontuxizumab Biosimilar

Target Type: Biosimilar

Background: Endosialin, TEM1, CD164L1, Tumor endothelial marker 1, CD248

UniProt: Q9HCU0

CAS-No: 946415-62-9